Clinical Trial Update: Quality of Life Validation in Laryngitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on quality-of-life validation for laryngopharyngeal reflux (LPR); the study is completed with AstraZeneca as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngopharyngeal Reflux

Snippet

Sponsor: AstraZeneca | Conditions: Laryngopharyngeal Reflux (LPR) | Phase 4 | Status: COMPLETED